Commercial insight into the pharma and biotech sector.

EvaluatePharma® delivers unique commercial insight into the past and future performance of the pharma and biotech sector, in a user-friendly online subscription service.

Data: Content, Sources and Updates

  • Comprehensive coverage of top 500 companies
  • Over 20,000 products, Marketed and in R&D
  • Reported Drug Sales from 1986: Worldwide, USA, EU & Japan
  • Consensus Product Forecasts to 2012 – 3,000 products (US & Worldwide)
  • Dynamic Archive of Forecasts, from 2003
  • Company Financials (incl. forecasts)
  • Deals, Royalty and Joint-Venture Revenue
  • Patent Expiries
  • Therapy Areas
  • Worldwide and US market analysis

…and much more

Data Sources

  • SEC filings—10-K, 10-Q, 20-F
  • Company annual and quarterly reports
  • Company press releases
  • Analysts meetings
  • Equity Analysts’ Research Reports
  • FDA and US Patent Office

EvaluatePharma®’s intuitive online interface makes it simple to find what you need. Easily customize reports to meet your market analysis needs by selecting from 100’s of data items:

  • Deal Types
  • Royalty Revenues
  • Detailed Financials
  • Financial Ratios
  • Technologies
  • Product Sourcing Strategies
  • Phase of development
  • Key Patent Comments
  • Pharmacological Classes
  • Indications
  • Over 1900 Originator Entities
  • Brands
  • Generics
  • EphMRA ATC Codes

…Plus more

Where to next?

View the Product FAQ
About You - find out how our data benefits our customers
Read some sample reports

 

Subscriptions

EvaluatePharma® delivers unique commercial insight into the past and future performance of the pharma and biotech sector, in a user-friendly online subscription service.

Sign-up Now!